Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses
Research and development	$ 1,659,075	$ 1,684,215	$ 4,250,934	$ 5,747,399
General and administrative	1,849,741	1,613,983	6,130,698	8,901,197
Total operating expenses	3,508,816	3,298,198	10,381,632	14,648,596
Operating loss	(3,508,816)	(3,298,198)	(10,381,632)	(14,648,596)
Other income	17,745	12,284	36,999	26,846
Loss before income taxes	(3,491,071)	(3,285,914)	(10,344,633)	(14,621,750)
Income taxes
Net loss	$ (3,491,071)	$ (3,285,914)	$ (10,344,633)	$ (14,621,750)
Loss per common share - basic and diluted (in dollars per share)	$ (0.34)	$ (0.36)	$ (1.09)	$ (1.77)
Weighted average shares outstanding - basic and diluted (in shares)	10,162,770	9,130,057	9,496,222	8,283,302